We are pleased to announce that Episode 9 of The Next Biggest Winner, a leading and nationally televised investment show focusing on small-cap and mid-cap companies aired this past weekend.
EPISODE 9 GUESTS
Avivagen Inc. (TSX VENTURE:VIV)
DealNet Capital Corp. (CNSX:DLS)
SEGMENT 1 – Cameron Groome, Chief Executive Officer of Avivagen joins us to discuss the company’s proprietary and patent-protected technology which supports the body’s own systems to maintain and enhance health, particularly by supporting immune function. Avivagen’s commercial-stage application of its technology is Fully-Oxidized beta-Carotene (OxC-beta).
SEGMENT 2 – Robert Cariglia, President of DealNet Capital Corp. discusses the company’s flexible investment mandate with a strategic focus on recurring revenue businesses. The company has recently focused its investments towards the thriving North American Business Process Outsourcing (BPO) Market as well as the Consumer Financing Market by leveraging its recently acquired BPO division.
SEGMENT 3 – Round Up! Both guests take the stage for a final round of questions.
Tags: Avivagen Inc., DealNet Capital